Windtree Therapeutics Inc - ESG Rating & Company Profile powered by AI
This dashboard includes a Q&A section on Windtree Therapeutics Inc. This analysis of Windtree Therapeutics Inc leverages data from across the web as well as from public documents by Windtree Therapeutics Inc. This assessment of Windtree Therapeutics Inc was prepared by All Street Sevva using cutting edge artificial intelligence.
Windtree Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 4.0, social score of 2.7 and governance score of 3.4.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1617 | VistaGen Therapeutics Inc | 3.5 | Medium |
| 1617 | Yumanity Therapeutics Inc | 3.5 | Medium |
| 1659 | Windtree Therapeutics Inc | 3.4 | Medium |
| 1659 | Acceleron Pharma Inc | 3.4 | Medium |
| 1659 | Annexin Pharmaceuticals AB (publ) | 3.4 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Windtree Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Windtree Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Windtree Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Windtree Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Windtree Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Windtree Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Windtree Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Windtree Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Windtree Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Windtree Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Windtree Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Windtree Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Windtree Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Windtree Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Windtree Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Windtree Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Windtree Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Windtree Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.